Cargando…
Registry study of immune-related adverse events using electronic patient-reported outcome in patients with cancer receiving immune checkpoint inhibitors: protocol for a multicentre cohort study
INTRODUCTION: The use of immune checkpoint inhibitors (ICIs) is rapidly expanding in cancer treatment. ICIs have a unique safety profile, characterised by immune-related adverse events (irAEs). The safety profile of ICIs lacks patient experience and perspectives. This study primarily aims to obtain...
Autores principales: | Hirata, Taiki, Kawaguchi, Takashi, Azuma, Kanako, Torii, Ayako, Usui, Hiroaki, Kim, Soan, Hayama, Tatsuya, Hirate, Daisuke, Kawahara, Yosuke, Kumihashi, Yuki, Chisaka, Tomomi, Wako, Tetsuya, Yoshimura, Akinobu, Miyaji, Tempei, Yamaguchi, Takuhiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10668225/ https://www.ncbi.nlm.nih.gov/pubmed/37993166 http://dx.doi.org/10.1136/bmjopen-2023-073724 |
Ejemplares similares
-
The Japanese version of the National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE): psychometric validation and discordance between clinician and patient assessments of adverse events
por: Kawaguchi, Takashi, et al.
Publicado: (2018) -
Tackling the Pharmaceutical Frontier: Regulation of Cannabinoid-Based Medicines in Postwar Japan
por: Miyaji, Tempei, et al.
Publicado: (2016) -
Assessment of Cancer-Related Fatigue, Pain, and Quality of Life in Cancer Patients at Palliative Care Team Referral: A Multicenter Observational Study (JORTC PAL-09)
por: Iwase, Satoru, et al.
Publicado: (2015) -
Integrated communication support program for oncologists, caregivers and patients with rapidly progressing advanced cancer to promote patient-centered communication: J-SUPPORT 1904 study protocol for a randomised controlled trial
por: Fujimori, Maiko, et al.
Publicado: (2020) -
The clinical use of Kampo medicines (traditional Japanese herbal treatments) for controlling cancer patients’ symptoms in Japan: a national cross-sectional survey
por: Iwase, Satoru, et al.
Publicado: (2012)